Projections indicate this market will reach around USD 1.3 billion in 2025, expanding to USD 2.292.6 billion by the early 2030s
Introduction P|ESG Approach Impact Ambitions 19 2025 Corporate Responsibility & P|ESG Highlights In 2025, we continued to advance our Corporate Responsibility and P|ESG efforts, focusing on strengthening existing processes and maintaining alignment with evolving regulatory and stakeholder expectations
Individual responses to medications vary significantly, and the right choice depends on your personal circumstances
Longitudinal analysis of obesity drug use and public awareness
Mnnist, S., Kontto, J., Kataja-Tuomola, M., Albanes, D., & Virtamo, J
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans